Emergency Medicine Cardiac Research and Education Group

NAVIGATION



ACTION Registry
ACTION Registry®–GWTG™ is a national, risk-adjusted, outcomes-based quality improvement program that helps participating facilities measure and improve care for high-risk ACS patients with STEMI and NSTEMI. The result of the collaboration between the two leading national coronary artery disease registries, the NCDR® ACTION Registry® and the American Heart Association (AHA) Get With The GuidelinesSM-CAD Registry, ACTION Registry–GWTG will be the largest, most comprehensive national cardiovascular patient database ever developed by the medical profession.

Combining the strengths of the two programs, ACTION Registry–GWTG will collect a comprehensive set of data elements that provide healthcare professionals and their facilities with the information they need to monitor and improve adherence to the most current, science-based ACC/AHA treatment guidelines. Participation will greatly facilitate quality improvement efforts, optimize clinical care, and improve clinical outcomes for acute coronary syndrome patients.

Visit How To Join to request additional information or to download an enrollment package. Or, visit the ACTION website for more information.



EMCREG-International PDA Hand Held Tools

CinciStroke and CinciACS are Palm OS handheld applications with an additional web-based version compatible on any handheld and desktop, designed to help clinicians with the acute management of Stroke and Acute Coronary Syndrome. Both tools offer interactive features and are based on the recent 2007 guidelines from the American Heart Association.

CinciStroke has interactive calculators for the NIH Stroke Scale, tPA dosing, heparin reversal, ICH Score, and prehospital stroke scales. CinciStroke also has features assisting clinicians with management of elevated INR, stroke syndromes, blood pressure management and much, much more. CinciACS is equally comprehensive and offers calculators for heparin dosing, GPIIb/IIIa inhibitors, TIMI & GRACE risk scores as well as management of STEMI and non-STEMI patients.

CinciACS also has tools for localizing infarctions by ECG, identifying a posterior and right sided MI and updated management of patients with cocaine abuse. Both applications were developed in conjunction with HandHeldDoc.com.


WEB-BASED INTERNET VERSION: These tools are available through any iPhone, Blackberry, PocketPC, Palm handheld browser, or desktop browser at http://www.handhelddoc.com/mobile.

PALM OS VERSIONS: The Palm OS version of these tools are available below:

CinciACS Tool
CinciStroke Tool
CinciACS PDA ToolCinciStroke PDA Tool
Download CinciACS Tool
Download CinciStroke Tool




[Return to previous page]
Legal information

EMCREG™ - International
4555 Lake Forest Drive
Suite 650
Cincinnati, Ohio 45242

Fell free to contact us toll-free at 1-866-4EMCREG (436-2734)



Advanced Search

5 March 2010
64-slice CT shows promise in cardiac risk stratification.
Computed tomography angiography provides important additional prognostic information, but it's role in clinical practice is still not known.
11 February 2010
Novel biomarker-guided strategy optimizes dosing in highest-risk HF patients.
Researchers report that a novel method for using natriuretic-peptide testing can optimize postdischarge therapy after acute heart-failure decompensation, reduce hospitalization, and improve outcomes.
28 January 2010
TIMI score predicts ACS outcome in emergency-setting
Study results show that the TIMI risk score predicts outcomes in emergency department with suspected ACS.
28 January 2010
Serial NT-proBNP measurements help in elderly HF risk prediction.
Serial measurement of NT-proBNP predicts new-onset heart failure and cardiovascular mortality in elderly.
15 January 2010
Ticagrelor beneficial in ACS patients undergoing invasive treatment.
Results of the PLATO trial show that the reversible P2Y12 inhibitor ticagrelor reduces death and cardiovascular events compared with clopidogrel therapy in ACS patients.
15 January 2010
Individual risk profiling for ACS patients can optimize antithrombotic treatment
Individual risk profiling of ACS patients could optimize therapeutic treatment choices.
5 January 2010
High sensitive cardiac troponin I level found to be a good prognostic marker in chronic HF
Study shows that high sensitive cardiac troponin I level is a useful prognostic marker of mortality in chronic heart failure patients.
23 December 2009
Largest meta-analysis ever reports that CRP not causal for CVD.
The largest and most comprehensive meta-analysis ever concludes that CRP is unlikely to be a causal factor for cardiovascular disease.
16 December 2009
Day and time of STEMI presentation may explain continued fibrinolytic therapy at PCI capable centers.
Research shows that a substantial number of STEMI patients still receive fibrinolytic therapy at PCI capable centers.
11 December 2009
Bleeding risk associated with AMI antithrombotic treatment increases the more antithrombotic drugs used.
Denmark researchers report in Lancet that relative risk for hospitalization for bleeding increased with all drug combinations and with each additional drug used.
3 December 2009
Prehospital triage of STEMI PCI patients independently improves outcome
Researchers report that prehospital triage significantly reduces treatment delay and improves outcomes in STEMI patients who undergo PCI.
30 November 2009
"Ischemic time" determines degree of reversible myocardial injury in PCI for STEMI.
Researchers report that the to reperfusion, beginning with symptom onset time, determines the extent of reversible myocardial injury in STEMI patients undergoing PCI.
NEWS ARCHIVES:
View recent archives...
©Copyright EMCREG-International™. All rights reserved